Exhibit 32(a)


              CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                 PURSUANT TO 18 U.S.C. SECTION 1350,
                       AS ADOPTED PURSUANT TO
            SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the IGENE Biotechnology, Inc. (the "Company")
Quarterly  Report  on Form 10-QSB/A for the period  ended  March  31,
2004,  as  filed with the Securities and Exchange Commission  on  the
date  hereof  (the  "Report"), I, Stephen F. Hiu,  President  of  the
Company,  certify  pursuant to 18 U.S.C.  Section  1350,  as  adopted
pursuant  to Section 906 of the Sarbanes-Oxley Act of 2002, that,  to
the best of my knowledge:

          (1).  The  Report  fully complies with the requirements  of
          Section  13(a) or 15(d) of the Securities Exchange  Act  of
          1934, as amended; and

          (2).   The  information  contained  in  the  Report  fairly
          presents, in all material respects, the financial condition
          and results of operations of the Company.


Date: September 28, 2005           By:  /s/ STEPHEN F. HIU
                                       ______________________________
                                            STEPHEN F. HIU
                                            President


A  signed original of this written statement required by Section  906
has  been provided to the Company and will be retained by the Company
and  furnished to the Securities and Exchange Commission or its staff
upon request.